Related Experiment Videos
Orthotopic liver transplantation for primary sclerosing cholangitis
J W Marsh1, S Iwatsuki, L Makowka
1Department of Surgery, University Health Center of Pittsburgh, University of Pittsburgh, Pennsylvania.
Annals of Surgery
|January 1, 1988
Abstract:
The incidence or diagnostic rate of sclerosing cholangitis is increasing. Because of the lack of effective medical or surgical therapy for patients with end-stage liver disease and sclerosing cholangitis, results with orthotopic liver transplantation were examined. The results of 55 consecutive liver replacements for this disease were reviewed. The 1- and 2-year actuarial survival rates are 71% and 57%, respectively. Orthotopic liver transplantation for end-stage liver disease from sclerosing cholangitis has emerged as the most effective therapy.